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background:  The prognostic significance of resistant hypertension (RHT) against that of other established risk factors such as smoking 
has not been investigated.
Methods: We prospectively followed 2009treated hypertensive patients for a mean period of 3.6±1.8 years. At the baseline visit, a thorough 
clinical and laboratory examination was performed. Current smoking was recorded as smoking of at least one cigarette daily and RHT as 
office-based uncontrolled hypertension under at least 3 drugs including a diuretic or controlled hypertension under 4 or more drugs. Based 
on the smoking habits and RHT status, four groups were identified: non-smokers/not having RHT (n=1073, 53% of the total population), 
smokers/not-having RHT (n=404, 20%), non-smokers/having RHT (n=425, 21%) and smokers/having RHT (n=107, 5%). Endpoint of 
interest was cardiovascular morbidity defined as the composite of coronary heart disease and stroke and non-smokers/not having RHT 
served as the reference group.
Results:  During follow-up, 69 events occurred (9.6 cases per 1,000 person-years). Incidence rates of cardiovascular events were 5.63 
cases per 1,000 person-years in the non-smoker/not having RHT group, 13.45 cases per 1,000 person-years in the smoker/not-having 
RHT group, 13.95 cases per 1,000 person-years in the non-smoker/having RHT group and 15.15 cases per 1,000 person-years in the 
smoker/having RHT group. Unadjusted analysis showed that non-smokers/having RHT had comparable risk to smokers/not-having RHT 
(HR:2.2, CI: 1.2-3.9 vs HR:2.4, CI:1.3-4.6, p<0.01 for both) while the smoker/having RHT group exhibited the worse prognosis (HR:2.7, 
CI:1.1-6.7, p<0.05). After adjusting for established risk factors, the significant risk of the non-smokers/having RHT group was maintained 
yet attenuated, while the smoker/not having RHT group exhibited now the worse prognosis.
conclusion:  Smoking and RHT exhibit a similarlysignificant cardiovascular risk, while, after controlling for established risk factors, the 
smoker status remains as the most potent predictor among the two. Concurrent risk factors strengthen the cardiovascular risk of RHT to a 
greater extent compared to that of smoking.
